Loading...
Loading...
Among the 6 tracked institutional investors we monitor, INMB (INMUNE BIO INC) is held with a combined value of $3.22M across 2,485,927 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.49M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 4 funds reduced their position.
Total Institutional Value
$3.22M
Total Shares Held
2,485,927
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.49M | 0.00% | New |
| 2 | BlackRock, Inc. | $1.35M | 0.00% | -1.5% |
| 3 | STATE STREET CORP | $328.69K | 0.00% | -16.2% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $19.21K | 0.00% | New |
| 5 | FMR LLC | $15.36K | 0.00% | -3.6% |
| 6 | CITADEL ADVISORS LLC | $14.13K | 0.00% | -72.6% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of INMB with a position worth $1.49M, representing 0.00% of their portfolio. In total, 6 institutional investors hold INMB with a combined value of $3.22M.
In the most recent quarter, 2 funds opened a new position in INMB. Additionally, 4 reduced their positions.
Institutional investors hold $3.22M worth of INMB stock across 6 positions. The largest institutional holder is VANGUARD GROUP INC with $1.49M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For INMB, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their INMB positions.